Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after k...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Hindawi Limited
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9a4959b5e70640e2a7ea1e095584eeac |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9a4959b5e70640e2a7ea1e095584eeac |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9a4959b5e70640e2a7ea1e095584eeac2021-11-08T02:35:45ZMetabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities2090-215810.1155/2021/5497346https://doaj.org/article/9a4959b5e70640e2a7ea1e095584eeac2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5497346https://doaj.org/toc/2090-2158Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases.Yin LiZixin ShaHui PengHindawi LimitedarticleDiseases of the genitourinary system. UrologyRC870-923ENInternational Journal of Nephrology, Vol 2021 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Diseases of the genitourinary system. Urology RC870-923 |
| spellingShingle |
Diseases of the genitourinary system. Urology RC870-923 Yin Li Zixin Sha Hui Peng Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| description |
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases. |
| format |
article |
| author |
Yin Li Zixin Sha Hui Peng |
| author_facet |
Yin Li Zixin Sha Hui Peng |
| author_sort |
Yin Li |
| title |
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| title_short |
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| title_full |
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| title_fullStr |
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| title_full_unstemmed |
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
| title_sort |
metabolic reprogramming in kidney diseases: evidence and therapeutic opportunities |
| publisher |
Hindawi Limited |
| publishDate |
2021 |
| url |
https://doaj.org/article/9a4959b5e70640e2a7ea1e095584eeac |
| work_keys_str_mv |
AT yinli metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities AT zixinsha metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities AT huipeng metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities |
| _version_ |
1718443212586090496 |